Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 4040  
Type : Journal
Research teams : Kundl - Sandoz Biopharmaceuticals, Sandoz GmbH
Authors : Lamanna W.C, Heller K, Schneider D, Guerrasio R, Hampl V, Fritsch C, Schiestl M.
Title : The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion.
Reference : J Oncol Pharm Practice ;25,2: 269-278 2017
Level of Evidence : 
Level of evidence A+
Physical stability : 
Protein: Size Exclusion Chromatography 
Chemical stability : 
Protein: Peptide mapping
Protein: ionic chromatography
Capillary electrophoresis
Other methods : 
PH measurement 
Comments : 
Proteins: biological activity by cell culture
List of drugs
InjectionRituximab Anticancer drug
Stability in solutions Polyethylene Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
31 Day
Biosimilar
Stability in solutions Polypropylene Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
31 Day
Biosimilar
  Mentions Légales